Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: multiple sclerosis,treatment of (Click to remove) Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999 NEJM 340:945-953, , 1999 Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Alemtuzumab for Multiples Sclerosis: Who and When to treat? Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012 A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010 Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008 Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management The Neurologist 8:227-236, Frohman,E.,et al, 2002 Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999 Cladribine in Treatment of Chronic Progressive Multiple Sclerosis Lancet 344:3-13, Sipe,J.C.,et al, 1994 Interferon Beta-1b is Effective in Relapsing-Remitting MS Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993 Intrathecal Interferon in Multiple Sclerosis Arch Neurol 39:609-615, Jacobs,L.,et al, 1982 Intraspinal Steroid Therapy Neurol 31:168-171, Bernat,J.L., 1981 Showing articles 0 to 13 of 13